Can Orphenadrine Be Given Intramuscularly?
Yes, orphenadrine can be administered intramuscularly (IM), and this route is clinically established with proven bioavailability that equals or exceeds oral administration. 1
Route of Administration
Orphenadrine is available in both oral and intravenous formulations, as confirmed by perioperative guidelines that describe it as "an oral and intravenous centrally acting skeletal muscle relaxant." 2
The intramuscular route is a valid and effective option for orphenadrine administration. Research demonstrates that IM injection of orphenadrine hydrochloride achieves bioavailability equal to or greater than oral tablets. 1
IM administration provides significantly higher plasma concentrations in the first hour compared to oral dosing, making it the preferred route when rapid drug effects are clinically required. 1
Clinical Context and Pharmacology
Orphenadrine is structurally similar to diphenhydramine and functions as a centrally acting skeletal muscle relaxant with anticholinergic properties. 2
The medication is commonly administered both preoperatively and perioperatively in clinical practice. 2
Orphenadrine does not act directly on skeletal muscle; its precise mechanism of action remains unclear but appears to involve anticholinergic effects. 2
Important Safety Considerations
Anticholinergic adverse effects include confusion, anxiety, tremors, urinary retention, dry mouth, constipation, and cardiovascular instability. 2
Use with extreme caution in patients with tachycardia, cardiac decompensation, coronary insufficiency, cardiac arrhythmias, and in elderly patients. 2
Absolute contraindications include gastrointestinal tract obstruction, stenosing peptic ulcer disease, prostatic hypertrophy or bladder outlet obstruction, glaucoma, and myasthenia gravis. 2
Drug interactions: Orphenadrine potentiates anticholinergic effects when combined with other medications having anticholinergic properties. 2
Pediatric toxicity warning: Orphenadrine can cause profound toxicity in children after ingestion of small doses, with central anticholinergic syndrome manifesting as hallucinations and severe agitation. 3